Amendment SA4-SSA2-SB70

SB70-SSA2-SA4,169,16 2. “Doula services” means childbirth education and support services, including emotional and physical support provided during pregnancy, labor, birth, and the postpartum period.

SB70-SSA2-SA4,169,22 (b) The department shall request from the secretary of the federal department of health and human services any required waiver or any required amendment to the state plan for Medical Assistance to allow reimbursement for doula services provided by a certified doula. If the waiver or state plan amendment is granted, the department shall reimburse a certified doula under s. 49.46 (2) (b) 12p. for the allowable charges for doula services provided to Medical Assistance recipients.

SB70-SSA2-SA4,204 Section 204. 49.46 (2) (b) 12p. of the statutes is created to read:

SB70-SSA2-SA4,170,2 49.46 (2) (b) 12p. Doula services provided by a certified doula, as specified under s. 49.45 (30t).”.

SB70-SSA2-SA4,170,3 196. Page 374, line 11: after that line insert:

SB70-SSA2-SA4,170,4 “ Section 205. 46.995 (4) of the statutes is created to read:

SB70-SSA2-SA4,170,8 46.995 (4) The department shall ensure that any child who is eligible and who applies for the disabled children's long-term support program that is operating under a waiver of federal law receives services under the disabled children's long-term support program that is operating under a waiver of federal law.”.

SB70-SSA2-SA4,170,9 197. Page 374, line 11: after that line insert:

SB70-SSA2-SA4,170,10 “ Section 206. 51.44 (5) (bm) of the statutes is created to read:

SB70-SSA2-SA4,170,13 51.44 (5) (bm) Ensure that any child with a level of lead in his or her blood that is 3.5 or more micrograms per 100 milliliters of blood, as confirmed by one venous blood test, is eligible for services under the program under this section.

SB70-SSA2-SA4,9119 Section 9119. Nonstatutory provisions; Health Services.

SB70-SSA2-SA4,170,17 (1u) Early intervention services. The department of health services may develop a methodology to allocate moneys under s. 20.435 (7) (bt) across county programs.”.

SB70-SSA2-SA4,170,18 198. Page 374, line 11: after that line insert:

SB70-SSA2-SA4,170,19 “ Section 9119. Nonstatutory provisions; Health Services.

SB70-SSA2-SA4,171,3 (1w) Electrocardiogram screening pilot program. The department of health services shall develop a pilot program to provide electrocardiogram screenings for participants in middle school and high school athletics programs in Milwaukee and Waukesha Counties. From the appropriation under s. 20.435 (1) (b), in fiscal year 2024-25, the department shall award $4,172,000 in grants to local health departments, as defined under s. 250.01 (4), to implement the pilot program under this subsection. Participation in the pilot program by participants in middle school and high school athletics programs shall be optional.”.

SB70-SSA2-SA4,171,4 199. Page 374, line 11: after that line insert:

SB70-SSA2-SA4,171,5 “ Section 207. 253.19 of the statutes is created to read:

SB70-SSA2-SA4,171,13 253.19 Grants to free-standing pediatric teaching hospitals. From the appropriation under s. 20.435 (1) (b), the department shall award grants to free-standing pediatric teaching hospitals to fund programming related to parenting, educational needs of and supports for chronically ill children, and case management for children with asthma. A free-standing pediatric teaching hospital is eligible for a grant under this section only if the percentage of Medical Assistance recipient inpatient days at the free-standing pediatric teaching hospital calculated under s. 49.45 (3m) (b) 1. a. is greater than 45 percent.”.

SB70-SSA2-SA4,171,14 200. Page 374, line 11: after that line insert:

SB70-SSA2-SA4,171,15 “ Section 208. 15.197 (20) of the statutes is created to read:

SB70-SSA2-SA4,171,18 15.197 (20) Spinal cord injury council. (a) There is created in the department of health services a spinal cord injury council that, except as provided in par. (b), consists of the following members appointed by the department for 2-year terms:

SB70-SSA2-SA4,171,20 1. One member representing the University of Wisconsin School of Medicine and Public Health.

SB70-SSA2-SA4,171,21 2. One member representing the Medical College of Wisconsin.

SB70-SSA2-SA4,171,22 3. One member who has a spinal cord injury.

SB70-SSA2-SA4,171,23 4. One member who is a family member of a person with a spinal cord injury.

SB70-SSA2-SA4,171,24 5. One member who is a veteran who has a spinal cord injury.

SB70-SSA2-SA4,172,2 6. One member who is a physician specializing in the treatment of spinal cord injuries.

SB70-SSA2-SA4,172,3 7. One member who is a researcher in the field of neurosurgery.

SB70-SSA2-SA4,172,5 8. One member who is a researcher employed by the veterans health administration of the U.S. department of veterans affairs.

SB70-SSA2-SA4,172,8 (b) If the department of health services is unable to appoint a member specified in par. (a) 1. to 8., the department of health services may appoint a member representing the general public in lieu of the member so specified.

SB70-SSA2-SA4,209 Section 209. 255.45 of the statutes is created to read:

SB70-SSA2-SA4,172,11 255.45 Spinal cord injury research grants and symposia. (1) Definitions. In this section:

SB70-SSA2-SA4,172,12 (a) “Council” means the spinal cord injury council.

SB70-SSA2-SA4,172,13 (b) “Grant program” means the program established under sub. (2).

SB70-SSA2-SA4,172,21 (2) Grant program. The department shall establish a program to award grants, from the appropriation under s. 20.435 (1) (b), to persons in this state for research into spinal cord injuries. The purpose of the grants is to support research into new and innovative treatments and rehabilitative efforts for the functional improvement of people with spinal cord injuries, and research topics may include pharmaceutical, medical device, brain stimulus, and rehabilitative approaches and techniques. Grant recipients shall agree to present their research findings at symposia held by the department under sub. (3).

SB70-SSA2-SA4,172,24 (3) Symposia. The department may hold symposia every 2 years for recipients of grants under the grant program to present findings of research supported by the grants.

SB70-SSA2-SA4,173,4 (4) Grant reports. By January 15 of each year, the department shall submit an annual report to the appropriate standing committees of the legislature under s. 13.172 (3) that identifies the recipients of grants under the grant program and the purposes for which the grants were used.

SB70-SSA2-SA4,173,5 (5) Council. (a) The council shall do all of the following:

SB70-SSA2-SA4,173,7 1. Develop criteria for the department to evaluate and award grants under the grant program.

SB70-SSA2-SA4,173,9 2. Review and make recommendations to the department on applications submitted under the grant program.

SB70-SSA2-SA4,173,10 3. Perform other duties specified by the department.

SB70-SSA2-SA4,173,14 (b) Each member of the council shall disclose in a written statement any financial interest in any organization that the council recommends to receive a grant under the grant program. The council shall include the written statements with its recommendations to the department on grant applications.

SB70-SSA2-SA4,9119 Section 9119. Nonstatutory provisions; Health Services

SB70-SSA2-SA4,173,18 (1) Spinal cord injury council; initial appointments. Notwithstanding the length of terms specified for the members of the spinal cord injury council under s. 15.197 (20) (a) (intro.), initial appointments to the council shall be made as follows:

SB70-SSA2-SA4,173,21 (a) The members appointed under s. 15.197 (20) (a) 1., 3., 5., and 7., or in lieu of those members under s. 15.197 (20) (b), shall be appointed for terms expiring on July 1, 2025.

SB70-SSA2-SA4,173,24 (b) The members appointed under s. 15.197 (20) (a) 2., 4., 6., and 8., or in lieu of those members under s. 15.197 (20) (b), shall be appointed for terms expiring on July 1, 2026.”.

SB70-SSA2-SA4,174,1 201. Page 374, line 11: after that line insert:

SB70-SSA2-SA4,174,2 “ Section 210. 256.158 of the statutes is created to read:

SB70-SSA2-SA4,174,3 256.158 Epinephrine for ambulances. (1) In this section:

SB70-SSA2-SA4,174,5 (a) “Ambulance service provider” means an ambulance service provider that is a public agency, volunteer fire department, or nonprofit corporation.

SB70-SSA2-SA4,174,7 (b) “Draw-up epinephrine” means epinephrine that is administered intramuscularly using a needle and syringe and drawn up from a vial or ampule.

SB70-SSA2-SA4,174,9 (c) “Draw-up epinephrine kit” means a single-use vial or ampule of draw-up epinephrine and a syringe for administration to a patient.

SB70-SSA2-SA4,174,11 (d) “Epinephrine auto-injector" means a device for the automatic injection of epinephrine into the human body.

SB70-SSA2-SA4,174,22 (2) From the appropriation under s. 20.435 (1) (b), the department shall reimburse ambulance service providers for a set of 2 epinephrine auto-injectors or a set of 2 draw-up epinephrine kits for each ambulance operating in the state. On an ongoing basis, the department shall, upon request from an ambulance service provider, reimburse the ambulance service provider for a replacement set of 2 epinephrine auto-injectors or a set of 2 draw-up epinephrine kits. The department shall allow the ambulance service provider to choose between epinephrine auto-injectors and draw-up epinephrine kits. The department may not reimburse an ambulance service provider for epinephrine unless each ambulance for which the ambulance service provider is reimbursed is staffed with an emergency medical services practitioner who is qualified to administer the provided epinephrine.”.

SB70-SSA2-SA4,174,23 202. Page 374, line 11: after that line insert:

SB70-SSA2-SA4,174,24 “ Section 211. 20.145 (1) (g) 5. of the statutes is created to read:

SB70-SSA2-SA4,175,4 20.145 (1) (g) 5. All moneys received from the regulation of pharmacy benefit managers, pharmacy benefit management brokers, pharmacy benefit management consultants, pharmacy services administration organizations, and pharmaceutical representatives.”.

SB70-SSA2-SA4,175,5 203. Page 374, line 11: after that line insert:

SB70-SSA2-SA4,175,6 “ Section 212. 15.07 (3) (bm) 7. of the statutes is created to read:

SB70-SSA2-SA4,175,8 15.07 (3) (bm) 7. The prescription drug affordability review board shall meet at least 4 times each year.

SB70-SSA2-SA4,213 Section 213. 15.735 of the statutes is created to read:

SB70-SSA2-SA4,175,12 15.735 Same; attached board. (1) There is created a prescription drug affordability review board attached to the office of the commissioner of insurance under s. 15.03. The board shall consist of the following members:

SB70-SSA2-SA4,175,13 (a) The commissioner of insurance or his or her designee.

SB70-SSA2-SA4,175,17 (b) Two members appointed for 4-year terms who represent the pharmaceutical drug industry, including pharmaceutical drug manufacturers and wholesalers. At least one of the members appointed under this paragraph shall be a licensed pharmacist.

SB70-SSA2-SA4,175,19 (c) Two members appointed for 4-year terms who represent the health insurance industry, including insurers and pharmacy benefit managers.

SB70-SSA2-SA4,175,22 (d) Two members appointed for 4-year terms who represent the health care industry, including hospitals, physicians, pharmacies, and pharmacists. At least one of the members appointed under this paragraph shall be a licensed practitioner.

SB70-SSA2-SA4,175,24 (e) Two members appointed for 4-year terms who represent the interests of the public.

SB70-SSA2-SA4,176,3 (2) A member appointed under sub. (1), except for a member appointed under sub. (1) (b), may not be an employee of, a board member of, or a consultant to a drug manufacturer or trade association for drug manufacturers.

SB70-SSA2-SA4,176,8 (3) Any conflict of interest, including any financial or personal association, that has the potential to bias or has the appearance of biasing an individual's decision in matters related to the board or the conduct of the board's activities shall be considered and disclosed when appointing that individual to the board under sub. (1).

SB70-SSA2-SA4,214 Section 214. Subchapter VI (title) of chapter 601 [precedes 601.78] of the statutes is created to read:

SB70-SSA2-SA4,176,11 CHAPTER 601

SB70-SSA2-SA4,176,13 SUBCHAPTER VI Prescription drug

SB70-SSA2-SA4,176,14 affordability review board

SB70-SSA2-SA4,215 Section 215. 601.78 of the statutes is created to read:

SB70-SSA2-SA4,176,16 601.78 Definitions. In this subchapter:

SB70-SSA2-SA4,176,18 (1) “Biologic” means a drug that is produced or distributed in accordance with a biologics license application approved under 21 CFR 601.20.

SB70-SSA2-SA4,176,20 (2) “Biosimilar” means a drug that is produced or distributed in accordance with a biologics license application approved under 42 USC 262 (k) (3).

SB70-SSA2-SA4,176,22 (3) “Board” means the prescription drug affordability review board established under s. 15.735 (1).

SB70-SSA2-SA4,176,25 (4) “Brand name drug” means a drug that is produced or distributed in accordance with an original new drug application approved under 21 USC 355 (c), other than an authorized generic drug, as defined in 42 CFR 447.502.

SB70-SSA2-SA4,177,3 (5) “Financial benefit” includes an honorarium, fee, stock, the value of the stock holdings of a member of the board or any immediate family member, and any direct financial benefit deriving from the finding of a review conducted under s. 601.79.

SB70-SSA2-SA4,177,4 (6) “Generic drug” means any of the following:

SB70-SSA2-SA4,177,6 (a) A retail drug that is marketed or distributed in accordance with an abbreviated new drug application approved under 21 USC 355 (j).

SB70-SSA2-SA4,177,7 (b) An authorized generic drug, as defined in 42 CFR 447.502.

SB70-SSA2-SA4,177,9 (c) A drug that entered the market prior to 1962 and was not originally marketed under a new drug application.

SB70-SSA2-SA4,177,12 (7) “Immediate family member” means a spouse, grandparent, parent, sibling, child, stepchild, or grandchild or the spouse of a grandparent, parent, sibling, child, stepchild, or grandchild.

SB70-SSA2-SA4,177,13 (8) “Manufacturer” means an entity that does all of the following:

SB70-SSA2-SA4,177,16 (a) Engages in the manufacture of a prescription drug product or enters into a lease with another manufacturer to market and distribute a prescription drug product under the entity's own name.

SB70-SSA2-SA4,177,18 (b) Sets or changes the wholesale acquisition cost of the prescription drug product described in par. (a).

SB70-SSA2-SA4,177,19 (9) “Pharmacy benefit manager” has the meaning given in s. 632.865 (1) (c).